Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000520545 | SCV000617794 | pathogenic | not provided | 2017-07-17 | criteria provided, single submitter | clinical testing | The W39X variant in the TYR gene has been reported previously in an individual with oculocutaneous albinism type 1B who also harbored a missense pathogenic variant on the other TYR allele (King et al., 2003). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The W39X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret W39X as a pathogenic variant. |
Genome- |
RCV001591179 | SCV001821917 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000520545 | SCV003440455 | pathogenic | not provided | 2022-10-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 449541). This premature translational stop signal has been observed in individual(s) with ocular albinism (PMID: 13680365, 27734839). This variant is present in population databases (rs775683960, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Trp39*) in the TYR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYR are known to be pathogenic (PMID: 23504663). |
Baylor Genetics | RCV004568665 | SCV005054561 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2024-03-20 | criteria provided, single submitter | clinical testing |